NEW DELHI: Glenmark Pharmaceuticals on Wednesday said its board has approved a proposal to offload the remaining 7.8% stake in Glenmark Life Sciences via an OFS, in a deal valued at around Rs 778 crore. The shares will be sold at a floor price of Rs 810 per share.
